• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带有 X 连锁性视网膜劈裂症 RS1(E72K)突变的视网膜类器官表现出感光器发育延迟,并可通过基因增强治疗得到挽救。

Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.

机构信息

Aier School of Ophthalmology, Central South University, Changsha, Hunan, China.

Aier Eye Institute, Changsha, Hunan, China.

出版信息

Stem Cell Res Ther. 2024 May 31;15(1):152. doi: 10.1186/s13287-024-03767-4.

DOI:10.1186/s13287-024-03767-4
PMID:38816767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11140964/
Abstract

BACKGROUND

X-linked juvenile retinoschisis (XLRS) is an inherited disease caused by RS1 gene mutation, which leads to retinal splitting and visual impairment. The mechanism of RS1-associated retinal degeneration is not fully understood. Besides, animal models of XLRS have limitations in the study of XLRS. Here, we used human induced pluripotent stem cell (hiPSC)-derived retinal organoids (ROs) to investigate the disease mechanisms and potential treatments for XLRS.

METHODS

hiPSCs reprogrammed from peripheral blood mononuclear cells of two RS1 mutant (E72K) XLRS patients were differentiated into ROs. Subsequently, we explored whether RS1 mutation could affect RO development and explore the effectiveness of RS1 gene augmentation therapy.

RESULTS

ROs derived from RS1 (E72K) mutation hiPSCs exhibited a developmental delay in the photoreceptor, retinoschisin (RS1) deficiency, and altered spontaneous activity compared with control ROs. Furthermore, the delays in development were associated with decreased expression of rod-specific precursor markers (NRL) and photoreceptor-specific markers (RCVRN). Adeno-associated virus (AAV)-mediated gene augmentation with RS1 at the photoreceptor immature stage rescued the rod photoreceptor developmental delay in ROs with the RS1 (E72K) mutation.

CONCLUSIONS

The RS1 (E72K) mutation results in the photoreceptor development delay in ROs and can be partially rescued by the RS1 gene augmentation therapy.

摘要

背景

X 连锁青年性视网膜劈裂症(XLRS)是一种由 RS1 基因突变引起的遗传性疾病,导致视网膜分裂和视力障碍。RS1 相关视网膜变性的机制尚未完全阐明。此外,XLRS 的动物模型在 XLRS 的研究中有其局限性。在这里,我们使用人诱导多能干细胞(hiPSC)衍生的视网膜类器官(RO)来研究 XLRS 的发病机制和潜在治疗方法。

方法

从两名 RS1 突变(E72K)XLRS 患者的外周血单核细胞中重编程的 hiPSC 分化为 RO。随后,我们探讨了 RS1 突变是否会影响 RO 的发育,并探索了 RS1 基因增强治疗的效果。

结果

源自 RS1(E72K)突变 hiPSC 的 RO 在感光细胞、视蛋白(RS1)缺乏和自发活动改变方面表现出发育迟缓,与对照 RO 相比。此外,发育迟缓与杆状细胞特异性前体标志物(NRL)和光感受器特异性标志物(RCVRN)的表达减少有关。在感光细胞未成熟阶段,腺相关病毒(AAV)介导的 RS1 基因增强治疗挽救了携带 RS1(E72K)突变的 RO 中的杆状光感受器发育迟缓。

结论

RS1(E72K)突变导致 RO 中的感光细胞发育迟缓,RS1 基因增强治疗可部分挽救。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/3b3aae86f010/13287_2024_3767_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/52199b0a9c42/13287_2024_3767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/f9d598e67aa9/13287_2024_3767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/26aa49f7982f/13287_2024_3767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/4d0e4c9b21d4/13287_2024_3767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/6fabc51ef98c/13287_2024_3767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/503bedc684f0/13287_2024_3767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/3b3aae86f010/13287_2024_3767_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/52199b0a9c42/13287_2024_3767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/f9d598e67aa9/13287_2024_3767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/26aa49f7982f/13287_2024_3767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/4d0e4c9b21d4/13287_2024_3767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/6fabc51ef98c/13287_2024_3767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/503bedc684f0/13287_2024_3767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/11140964/3b3aae86f010/13287_2024_3767_Fig7_HTML.jpg

相似文献

1
Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.携带有 X 连锁性视网膜劈裂症 RS1(E72K)突变的视网膜类器官表现出感光器发育延迟,并可通过基因增强治疗得到挽救。
Stem Cell Res Ther. 2024 May 31;15(1):152. doi: 10.1186/s13287-024-03767-4.
2
Early Developmental Characteristics and Features of a Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis.X 连锁青年性视网膜劈裂症的三维视网膜类器官模型的早期发育特征
Int J Mol Sci. 2024 Jul 27;25(15):8203. doi: 10.3390/ijms25158203.
3
Morphological and Molecular Defects in Human Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis.X 连锁青年性视网膜劈裂症的人三维视网膜类器官模型的形态和分子缺陷。
Stem Cell Reports. 2019 Nov 12;13(5):906-923. doi: 10.1016/j.stemcr.2019.09.010. Epub 2019 Oct 24.
4
Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.通过腺相关病毒-RS1转移对成年视网膜劈裂症小鼠进行突触病理学研究及治疗性修复
J Clin Invest. 2015 Jul 1;125(7):2891-903. doi: 10.1172/JCI81380. Epub 2015 Jun 22.
5
Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.关于人类与小鼠:人类X连锁视网膜劈裂症及小鼠建模的准确性
Prog Retin Eye Res. 2022 Mar;87:100999. doi: 10.1016/j.preteyeres.2021.100999. Epub 2021 Aug 11.
6
Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.羧基化纳米金刚石介导的 CRISPR-Cas9 递送人源视网膜劈裂症突变基因至人诱导多能干细胞和小鼠视网膜
Acta Biomater. 2020 Jan 1;101:484-494. doi: 10.1016/j.actbio.2019.10.037. Epub 2019 Oct 28.
7
Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.眼内注射 AAV8-RS1 基因治疗 X 连锁性视网膜劈裂症:I/IIa 期临床试验初步结果
Mol Ther. 2018 Sep 5;26(9):2282-2294. doi: 10.1016/j.ymthe.2018.05.025. Epub 2018 Jul 7.
8
The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS.X连锁青少年视网膜劈裂症基因治疗之路:XLRS细胞模型和啮齿动物模型临床前基因治疗的系统评价
Int J Mol Sci. 2024 Jan 19;25(2):1267. doi: 10.3390/ijms25021267.
9
Identifying Multiomic Signatures of X-Linked Retinoschisis-Derived Retinal Organoids and Mice Harboring Patient-Specific Mutation Using Spatiotemporal Single-Cell Transcriptomics.利用时空单细胞转录组学鉴定携带患者特异性突变的X连锁视网膜劈裂衍生视网膜类器官和小鼠的多组学特征。
Adv Sci (Weinh). 2025 Jan;12(1):e2405818. doi: 10.1002/advs.202405818. Epub 2024 Nov 6.
10
Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.玻璃体腔内注射腺相关病毒-RS1基因疗法在X连锁视网膜劈裂小鼠模型中的临床前剂量递增研究:剂量依赖性表达及视网膜结构与功能改善
Hum Gene Ther. 2016 May;27(5):376-89. doi: 10.1089/hum.2015.142.

引用本文的文献

1
Damaging effect of ischemia on the development of retinal organoids derived from human embryonic stem cells.缺血对源自人类胚胎干细胞的视网膜类器官发育的损害作用。
Int J Ophthalmol. 2025 Aug 18;18(8):1433-1449. doi: 10.18240/ijo.2025.08.03. eCollection 2025.
2
AAV2.7m8 transduction of stage 2 human retinal organoids induces highly variable responses in innate and inflammatory gene expression and cytokine secretion.2型腺相关病毒(AAV2.7m8)转导2期人类视网膜类器官会在先天性和炎症基因表达以及细胞因子分泌方面引发高度可变的反应。
Exp Eye Res. 2025 Jun 6;258:110478. doi: 10.1016/j.exer.2025.110478.
3
Retinal Organoids: Innovative Tools for Understanding Retinal Degeneration.

本文引用的文献

1
Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials.X连锁视网膜劈裂症的长期功能和结构转归:对临床试验的意义
Front Med (Lausanne). 2023 Jun 15;10:1204095. doi: 10.3389/fmed.2023.1204095. eCollection 2023.
2
AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype.AAV 介导的 CRB1 患者来源的视网膜类器官的基因增强治疗恢复了视网膜的组织学和转录表型。
Stem Cell Reports. 2023 May 9;18(5):1123-1137. doi: 10.1016/j.stemcr.2023.03.014. Epub 2023 Apr 20.
3
Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
视网膜类器官:理解视网膜变性的创新工具。
Int J Mol Sci. 2025 Apr 1;26(7):3263. doi: 10.3390/ijms26073263.
4
Organoids - the future of pre-clinical development of AAV gene therapy for CNS disorders.类器官——中枢神经系统疾病腺相关病毒基因治疗临床前开发的未来。
Gene Ther. 2025 Mar 27. doi: 10.1038/s41434-025-00527-8.
5
Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review.展望眼部基因治疗中病毒载体的未来:临床综述
Biomedicines. 2025 Feb 5;13(2):365. doi: 10.3390/biomedicines13020365.
6
A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases.AAV 介导的遗传性视网膜疾病基因治疗模型的比较分析。
Cells. 2024 Oct 15;13(20):1706. doi: 10.3390/cells13201706.
7
Retinal Organoids from Induced Pluripotent Stem Cells of Patients with Inherited Retinal Diseases: A Systematic Review.来自遗传性视网膜疾病患者诱导多能干细胞的视网膜类器官:一项系统综述。
Stem Cell Rev Rep. 2025 Jan;21(1):167-197. doi: 10.1007/s12015-024-10802-7. Epub 2024 Oct 18.
8
Early Developmental Characteristics and Features of a Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis.X 连锁青年性视网膜劈裂症的三维视网膜类器官模型的早期发育特征
Int J Mol Sci. 2024 Jul 27;25(15):8203. doi: 10.3390/ijms25158203.
器官芯片技术——从疾病模型到药物开发机遇的指南。
Biosens Bioelectron. 2023 Jul 1;231:115271. doi: 10.1016/j.bios.2023.115271. Epub 2023 Mar 31.
4
X-Linked Retinoschisis.X 连锁性视网膜炎劈裂
Cold Spring Harb Perspect Med. 2023 Sep 1;13(9):a041288. doi: 10.1101/cshperspect.a041288.
5
Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors.视网膜双极细胞靶向表达视锥视蛋白可促进 XLRS 患者 RS1 缺失型格子样变性的裂孔闭合而不影响感光细胞。
Invest Ophthalmol Vis Sci. 2022 Oct 3;63(11):8. doi: 10.1167/iovs.63.11.8.
6
Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis.视网膜类器官在整个视网膜发生过程中提供了对遗传性视网膜疾病分子特征的独特见解。
J Anat. 2023 Aug;243(2):186-203. doi: 10.1111/joa.13768. Epub 2022 Sep 29.
7
Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue.利用视网膜色素上皮和类器官结合基因增强挽救技术对PRPF31视网膜色素变性进行建模。
NPJ Regen Med. 2022 Aug 16;7(1):39. doi: 10.1038/s41536-022-00235-6.
8
Retinoschisin Deficiency Induces Persistent Aberrant Waves of Activity Affecting Neuroglial Signaling in the Retina.视网膜分裂蛋白缺乏会引发持续异常的活动波,影响视网膜中的神经胶质信号传导。
J Neurosci. 2022 Sep 7;42(36):6983-7000. doi: 10.1523/JNEUROSCI.2128-21.2022.
9
Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.眼内注射 rAAV2tYF-CB-hRS1 载体进行 X 连锁性视网膜劈裂症基因增强治疗的 1 年临床结果。
Ophthalmol Retina. 2022 Dec;6(12):1130-1144. doi: 10.1016/j.oret.2022.06.013. Epub 2022 Jun 30.
10
Self-Organization of the Retina during Eye Development, Retinal Regeneration In Vivo, and in Retinal 3D Organoids In Vitro.眼睛发育过程中视网膜的自我组织、体内视网膜再生以及体外视网膜三维类器官中的情况
Biomedicines. 2022 Jun 20;10(6):1458. doi: 10.3390/biomedicines10061458.